Targeted Therapies for Periocular Malignancies

Article initiated by:

Carisa E. Bohnak, MD, Gangadhara Sundar, MD

All authors and contributors:

Carisa E. Bohnak, MD

Assigned editor:

Review:

Assigned status Update Pending

.

add
Contributing Editors:	add

Introduction

The advent of immunotherapy over the last decades has drastically altered oncologic therapies for patients. Through our understanding of the normal immunological pathways, and the ways for which cancer cells have evolved to evade these pathways, therapies have been developed that allow a person's now immune system to target and destroy these cells.